Crohn's Disease Clinical Trials

Showing 1081-1088 of 1,088 trials

Crohn's Disease, Obesity and Disease Severity

NCT00488085

The aim of our study is to suggest possible underlying mechanisms for the observed clinical differences in disease severity and behavior of overweight and obese patients with crohn's disease(BMI \> 25 kg/m²)as compare to non-obese crohn's patients with a normal or low weight ( BMI ≤ 25) by measuring metabolic\\nutritional variables and cytokine levels.

Crohn's Disease, Obesity

Tel-Aviv Sourasky Medical Center40 participantsStarted Jun 2007

Tel Aviv, Israel

UNKNOWNPhase 2/3

Vitamin D Treatment for Crohn´s Disease

NCT00132184

The purpose of this study is to examine whether vitamin D treatment is effective in Crohn's disease.

Crohns Disease

University of Aarhus110 participantsStarted Sep 2005

Aarhus, Denmark • Horsens, Denmark • Randers, Denmark +1 more locations

UNKNOWNPhase 3

Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution.

NCT00204165

The purpose of this study is to compare MRI enteroclysis with MRI of the small bowel with a per oral 6%mannitol solution.Our hypothesis is that the peroral technique preform the same way as MRI Enteroclysis.

Magnetic Resonance Imaging, Intestine Small, Crohn Disease.

University of Oslo40 participantsStarted Nov 2004

Kirkeveien 166, Oslo, Norway

COMPLETEDNA

Treatment With Lactobacillus Rhamnosus and Lactobacillus Acidophilus for Patients With Active Colonic Crohn's Disease.

NCT00374374

The purpose of this study is to determine whether a probiotic containing Lactobacillus Acidophilus and Lactobacillus Rhamnosus is effective as treatment for patients with active colonic Crohn's disease

Crohn's Disease

Odense University Hospital30 participantsStarted May 2001

Odense, Denmark

Crohn's Disease, Obesity and Disease Severity

Vitamin D Treatment for Crohn´s Disease

Comparison of MR Enteroclysis and MRI With Per Oral Contrast Using a 6 % Mannitol Solution.

Treatment With Lactobacillus Rhamnosus and Lactobacillus Acidophilus for Patients With Active Colonic Crohn's Disease.

Related Searches

Study of the Human Anti-TNF Monoclonal Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

A Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects With Crohn's Disease

Beta Carotene From Natural Source for Patients With Non-Active Crohn's Disease

The RATIO: Registry of Infections and Lymphoma in Patients Treated With TNF-a Antagonists